Lv3
350 积分 2023-08-14 加入
[Chinese guidelines on the management of hepatic encephalopathy in cirrhosis (2024)]
8小时前
待确认
Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma
25天前
已完结
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma
27天前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
27天前
已完结
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
27天前
已完结
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis
2个月前
已完结
A Randomized, Controlled Trial of Postoperative Adjuvant Interferon Therapy After Resection of Hepatocellular Carcinoma
2个月前
已完结
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
2个月前
已完结
Immunotherapy at all stages of hepatocellular carcinoma
2个月前
已完结
Watch-and-Wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma：a propensity score-matching comparative study
3个月前
已完结
皖公网安备34019202002308
